News

Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow

WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a…

2 years ago

Checkpoint Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

WALTHAM, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…

2 years ago

Vaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission

A preclinical study in hamsters showed both a decrease in infectious virus and in transmission Phase 1 data measuring cross-reactivity also…

2 years ago

Tricida Announces Administrative Stop of the VALOR-CKD Trial

Expects to Announce Top-Line Results Early in the Fourth Quarter of 2022SOUTH SAN FRANCISCO, Calif., May 19, 2022 (GLOBE NEWSWIRE)…

2 years ago

TOMI CEO Dr. Halden Shane to Present at the H.C. Wainwright Global Investment Conference

FREDERICK, Md., May 19, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection…

2 years ago

WIMI Hologram Academy: Virtual Reality Technology Provides An Immersive Recovery Experience

HONG KONG, May 19, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

2 years ago

Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Cells Derived from Healthy, Younger Donors were More Abundant with Greater Fitness and Cancer Killing Potential Than Cells Derived from…

2 years ago

Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference

Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an…

2 years ago

Amarin Announces Appointment of New Directors and Board Leadership Changes

Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with…

2 years ago

Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years

Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment OptionsSANTA CLARA,…

2 years ago